Myelofibrosis natural history, complications and prognosis: Difference between revisions
Line 13: | Line 13: | ||
*[[Blood clots]] | *[[Blood clots]] | ||
*[[Hepatic failure]] | *[[Hepatic failure]] | ||
*[[Gout]] | |||
==Prognosis== | ==Prognosis== |
Revision as of 20:42, 7 March 2016
Myelofibrosis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Myelofibrosis natural history, complications and prognosis On the Web |
American Roentgen Ray Society Images of Myelofibrosis natural history, complications and prognosis |
FDA on Myelofibrosis natural history, complications and prognosis |
CDC on Myelofibrosis natural history, complications and prognosis |
Myelofibrosis natural history, complications and prognosis in the news |
Blogs on Myelofibrosis natural history, complications and prognosis |
Risk calculators and risk factors for Myelofibrosis natural history, complications and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]
Overview
Natural History
Complications
Common complications of myelofibrosis include:[1]
Prognosis
Myelofibrosis leads to progressive bone marrow failure. The mean survival is five years and causes of death include infection, bleeding, organ failure, portal hypertension, and leukemic transformation.
References
- ↑ Complications of myelofibrosis. US National Library of Medicine 2016. https://www.nlm.nih.gov/medlineplus/ency/article/000531.htm. Accessed on March 7, 2016